{"title":"Prevalence and prognosis from the disability related to spinal tuberculosis: a systematic review","authors":"Juanda Setiajaya","doi":"10.15562/ijbs.v16i1.384","DOIUrl":null,"url":null,"abstract":"Objective: To review the disabilities caused by Spinal TB in relation to the prevalence and prognosis of the disabilities caused by the disease.\nMethod: We conducted systematic search of the literatures based on PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) and PICO criteria. Our inclusion criteria were: 1) Patients with spinal TB; 2) full original articles; 3) articles written in English; 4) the period of publication of articles from 2012 to 2022. Evaluation of each article was done by checklist Strengthening the Reporting of Observational Studies in Epidemiology (STROBE).\nResults: From all articles in the publication year of 2012 to 2022, we reviewed five retrospective cohort studies, all studies coming from Asian countries. The five articles observed the prevalence of disabilities caused by spinal TB reflected through some important outcome variables pre-treatment, where they continued to compare with the post-treatment outcome variables. All of the studies reviewed had agreed that immediate or delayed treatment would give significant benefits to the patients of spinal TB, even better with combined treatments of conventional pre-operative anti-TB drugs and surgical intervention. It was found that poor prognosis associated with preoperative neurological status of the patients.\nConclusion: Conventional anti-TB drugs and surgical intervention can be of great help and benefit for patients with spinal TB, reducing their disabilities severity and improving their prognosis.","PeriodicalId":55769,"journal":{"name":"Indonesia Journal of Biomedical Science","volume":"22 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indonesia Journal of Biomedical Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15562/ijbs.v16i1.384","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To review the disabilities caused by Spinal TB in relation to the prevalence and prognosis of the disabilities caused by the disease.
Method: We conducted systematic search of the literatures based on PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) and PICO criteria. Our inclusion criteria were: 1) Patients with spinal TB; 2) full original articles; 3) articles written in English; 4) the period of publication of articles from 2012 to 2022. Evaluation of each article was done by checklist Strengthening the Reporting of Observational Studies in Epidemiology (STROBE).
Results: From all articles in the publication year of 2012 to 2022, we reviewed five retrospective cohort studies, all studies coming from Asian countries. The five articles observed the prevalence of disabilities caused by spinal TB reflected through some important outcome variables pre-treatment, where they continued to compare with the post-treatment outcome variables. All of the studies reviewed had agreed that immediate or delayed treatment would give significant benefits to the patients of spinal TB, even better with combined treatments of conventional pre-operative anti-TB drugs and surgical intervention. It was found that poor prognosis associated with preoperative neurological status of the patients.
Conclusion: Conventional anti-TB drugs and surgical intervention can be of great help and benefit for patients with spinal TB, reducing their disabilities severity and improving their prognosis.
目的:综述脊柱结核致残与脊柱结核致残患病率及预后的关系。方法:基于PRISMA (Preferred Reporting Items for systematic Reviews and meta - analysis)和PICO标准对文献进行系统检索。我们的入选标准是:1)脊柱结核患者;2)完整的原创文章;3)用英文写的文章;4)文章发表期为2012年至2022年。通过加强流行病学观察性研究报告(STROBE)检查表对每篇文章进行评估。结果:从2012年至2022年发表的所有文章中,我们回顾了5项回顾性队列研究,所有研究均来自亚洲国家。这五篇文章通过治疗前的一些重要结果变量观察到脊柱结核引起的残疾患病率,并继续与治疗后的结果变量进行比较。所有审查的研究都一致认为,立即或延迟治疗将给脊柱结核患者带来显著的益处,传统的术前抗结核药物和手术干预相结合的治疗效果更好。发现预后不良与患者术前神经系统状况有关。结论:常规抗结核药物和手术干预对脊柱结核患者有很大的帮助和益处,可减轻其残疾程度,改善其预后。